I. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease: Effects on Drinking Behavior by Nurse/Physician Teams

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 11, 2003, Pages 1757-1764

  Lieber, Charles S ^a,e   Weiss, David G ^b   Groszmann, Roberto ^c   Paronetto, Fiorenzo ^a   Schenker, Steven ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brief Invention; Control of Drinking

Indexed keywords

CHOLINE DERIVATIVE; PLACEBO; PLANT EXTRACT; POLYENE PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; GASTROENTEROLOGY; HEALTH VISITOR; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NURSE; PHYSICAL EXAMINATION; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SOLDIER; TELEPHONE;

ALCOHOL DRINKING; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; NURSE'S ROLE; PHOSPHATIDYLCHOLINES; PHYSICIAN'S ROLE; PROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 0344393712     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000093744.12232.34     Document Type: Article

References (25)

1. Allen JP, Litten RZ, Fertig JB (1995) NIDA-NIAAA workshop: efficacy of therapies in drug and alcohol addiction-strategies for treatment of alcohol problems. Psychopharmacol Bull 31:665-669.
2. Anton RF, Lieber CS, Tabakoff B (2002) Carbohydrate-deficient transferrin and γ-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 26:1215-1222.
3. Babor TF, Grant M (1992) Project on Identification and Management of Alcohol-Related Problems. Report on Phase II: A Randomized Clinical Trial of Brief Interventions in Primary Health Care. World Health Organization, Geneva.
4. Bien TH, Miller WR, Tonigan JS (1993) Brief interventions for alcohol problems: a review. Addiction 88:315-336.
5. Chafetz ME, Blane HT, Abram HS, Golner J, Lacy E, McCourt WF, Clark E, Meyers W (1962) Establishing treatment relations with alcoholics. J Nerv Ment Dis 134:395-409.
6. Davis WT, Campbell L, Tax J, Lieber CS (2002) A trial of "standard" outpatient alcoholism treatment vs. a minimal treatment control. J Subst Abuse Treat 23:9-19.
7. Fleming ME, Barry KL, Manwell LB, Johnson K, London R (1997) Brief physician advice for problem alcohol drinkers: a randomized controlled trial in community-based primary care practices. JAMA 277:1039-1045.
8. Fleming MF, Mundt MP, French MT, Manwell LB, Stauffachner EA (2002) Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res 26:36-43.
9. Fuller RK, Hiller-Sturmhofel S (1999) Alcoholism treatment in the United States: an overview. Alcohol Res Health 23:69-77.
10. Gottheil E, Thornton CC, Skoloda TE, Alterman AI (1982) Follow-up of abstinent and non-abstinent alcoholics. Am J Psychiatry 139:560-565.
11. Israel Y, Hollander O, Sanchez-Craig M, Booker S, Miller V, Gingrich R, Rankin JG (1996) Screening for problem drinking and counseling by the primary care physician-nurse team. Alcohol Clin Exp Res 20:1443-1450.
12. Lieber CS (1999) Carbohydrate deficient transferrin in alcoholic liver disease: mechanisms and clinical implications. Alcohol 19:249-254.
13. Lieber CS, Robins SJ, Li J, DeCarli LM, Mak KM, Fasulo JM, Leo MA (1994) Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106:152-159.
14. Lieber CS, Weiss D, Groszmann R, Paronetto F, Schenker S, for the Veterans Affairs Cooperative Study Group 391 (2003) II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 27:1765-1772.
15. Luckie LF, White RE, Miller WR, Icenogle MV, Lasoski MC (1995) Prevalence of alcohol problems in a VA outpatient population: AUDIT vs. MAST. J Clin Psychol 51:422-425.
16. Marlatt GA (1996) Harm reduction: come as you are. Addict Behav 21:779-788.
17. Mattick RP, Jarvis T (1994) Brief or minimal intervention for 'alcoholics'? The evidence suggests otherwise. Drug Alcohol Rev 13:137-144.
18. Miller WR, Walters ST, Bennett ME (2001) How effective is alcoholism treatment in the United States? J Stud Alcohol 62:211-220.
19. National Institute on Alcohol Abuse and Alcoholism (1999) Are Women More Vulnerable to Alcohol's Effect (Alcohol Alert No. 46)? National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
20. National Institute on Alcohol Abuse and Alcoholism (2000) New Advances in Alcoholism Treatment (Alcohol Alert No. 49). National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
21. Project MATCH (1997) Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 58:7-29.
22. Scott E, Anderson P (1990) Randomized controlled trial of general practitioner intervention in women with excessive alcohol consumption. Drug Alcohol Rev 10:313-321.
23. Stibler H (1991) Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-2037.
24. Vaillant GE, Clark W, Cyrus C, Milofsky ES, Kopp J, Wulsin VW, Mogielnicki NP (1983) Prospective study of alcoholism treatment. Am J Med 75:455-463.
25. Worner TM, Lieber CS (1985) Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254:627-630.